Metoclopramide Sugar-Free G.L. Pharma

Metoclopramide, the active ingredient in Metoclopramide Sugar-Free G.L. Pharma, is a dopamine D2 receptor antagonist presented as an oral tablet for oral use. It treats nausea, vomiting, gastroparesis and related gastrointestinal disorders.

GNH USA supplies Metoclopramide Sugar-Free G.L. Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide acts on the dopaminergic pathways that regulate nausea, vomiting and gastrointestinal motility. - Nausea and vomiting: alleviates acute, postoperative or chemotherapy‑induced nausea and vomiting. - Gastroparesis: enhances gastric emptying and reduces symptoms in delayed gastric emptying conditions. - Gastro‑oesophageal reflux disease (GERD): decreases reflux episodes by improving gastric motility. - Migraine‑associated nausea: controls nausea that accompanies migraine attacks.

Metoclopramide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: feeling unusually tired or weak. - Drowsiness: increased sleepiness, especially after dosing. - Headache: mild to moderate cranial pain. - Diarrhea: loose stools or increased bowel movements. - Abdominal cramps: discomfort or pain in the stomach area.

Serious or Rare Side Effects: - Tardive dyskinesia: involuntary, repetitive movements that may be irreversible. - Neuroleptic malignant syndrome: life‑threatening reaction with fever, muscle rigidity and autonomic instability. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Cardiac arrhythmias: abnormal heart rhythms. - Seizures: convulsive episodes. - Depression or suicidal thoughts: mood changes requiring immediate medical attention.

Before prescribing Metoclopramide, clinicians should evaluate patient‑specific factors and monitor for potential complications. - Assess patient history: review for Parkinson’s disease, seizure disorders, depression, or previous extrapyramidal reactions. - Monitor for extrapyramidal symptoms: observe for involuntary movements, rigidity or tremor during therapy. - Avoid prolonged use: limit duration to the shortest effective period to reduce risk of tardive dyskinesia. - Use with caution in elderly: older adults have increased susceptibility to central nervous system side effects. - Store at ambient temperature: keep below 25°C, protect from moisture in the original packaging.

Metoclopramide can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticholinergic agents: may diminish the pro‑kinetic effect of metoclopramide. - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): increase metoclopramide plasma concentrations. - Other dopamine antagonists: additive risk of extrapyramidal symptoms. - MAO inhibitors: potential for hypertensive crisis when combined. - Serotonergic drugs (e.g., triptans, SSRIs): heightened risk of serotonin syndrome.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., alcohol, benzodiazepines): enhanced sedation and drowsiness. - Antihistamines: may increase central nervous system depression. - Antidiabetic agents: possible alteration of glucose control requiring monitoring.